Resident physicians in the Department of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Medical Student, Department of Pulmonary and Critical Care Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Mo Med. 2022 Nov-Dec;119(6):545-552.
Chronic obstructive pulmonary disease (COPD) is not merely a lung disease as the name indicates. Patients with COPD experience associated complications with systemic inflammation, heart strain, muscle wasting, poor functional performance, and psychological issues. An assessment of these patients based only on lung function tests or functional capacity would be inadequate. Many studies have reported the significance and prognostic value of several laboratory tests. Troponin, C-reactive protein (CRP), hemoglobin, and carbon dioxide are older tests but compared with the newly developed tests, they are relatively inexpensive to measure and widely available. This article will review laboratory tests used for COPD and discuss their prognostic value. The laboratory tests that can identify high-risk patients will be discussed. We will explore the role of these tests in clinical practice.
慢性阻塞性肺疾病(COPD)的名称表明,它不仅仅是一种肺部疾病。COPD 患者会出现全身炎症、心脏紧张、肌肉消耗、功能表现不佳和心理问题等相关并发症。仅基于肺功能测试或功能能力对这些患者进行评估是不够的。许多研究报告了几种实验室测试的意义和预后价值。肌钙蛋白、C 反应蛋白(CRP)、血红蛋白和二氧化碳是较旧的测试,但与新开发的测试相比,它们的测量相对便宜且广泛可用。本文将综述用于 COPD 的实验室测试,并讨论其预后价值。将讨论可识别高危患者的实验室测试。我们将探讨这些测试在临床实践中的作用。